“…Recently, the successful use of an antiviral drug for hepatitis C has greatly encouraged the search for a cure for hepatitis B, which likely requires an approach focused on improving the antiviral immune response. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Their clinical success has shown strong effectiveness against several viruses, including ebolavirus, hepatitis C virus, HIV, MERS, SARS-Cov, and the most recent emergent SARS-Cov2. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Chronic hepatitis C virus (HCV) infections are a worldwide medical problem responsible for diverse types of liver diseases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In 2019, hepatitis B virus (HBV) and hepatitis C virus (HCV) resulted in an estimated 820,000 and 290,000 deaths, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Pegylated interferon is more effective than conventional alpha interferon and, given its reported results in relation to treating hepatitis C over the past decade, we hypothesized that this might be more effective than conventional interferon also for treating respiratory papillomatosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…None of the participants reported ever testing for Hepatitis C.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The most common cause of mixed cryoglobulinemia is hepatitis C virus (HCV), while other infections, including hepatitis B virus (HBV) and HIV infections, and lymphoproliferative and autoimmune disorders have also been associated with the disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Enzymology data from both DENV2 and hepatitis C virus (HCV) RdRPs suggest that critical transition of the refolding likely occurs after synthesis of a 4- to 5-nucleotide (nt) product together providing a key basis in understanding viral RdRP transition from initiation to elongation.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…For RSV and SARS-CoV-2, diabetes increases the risk of infection with the virus, in addition to viral infection increasing the risk for development of diabetes. For HIV and hepatitis C and E, enhanced TNF-a levels play a role in the detrimental effects. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Hepatitis C virus (HCV) infection represents a major public health burden with diverse epidemics worldwide, but at present, only a minority of infected persons have been tested and are aware of their diagnosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Two-hundred seventeen patients with chronic viral hepatitis caused by either hepatitis B virus (HBV) or hepatitis C virus (HCV) were enrolled. We divided the patients into two groups, one comprising 147 patients with chronic hepatitis B (CHB) (98 men and 49 women, average age 46.5 ± 12.2 years) and another comprising 70 patients with chronic hepatitis C (CHC) (47 men and 23 women, average age 47.6 ± 12.1 years). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Opioid use is escalating in North America and comes with a multitude of health consequences, including HIV and hepatitis C virus (HCV) outbreaks among persons who inject drugs (PWID). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In July 2001 Hemispherx Biopharma announced that it had formed a strategic alliance with Empire Health Resources for clinical trials of Ampligen® in the treatment of HIV and hepatitis C virus infections. Empire Health Resources, a healthcare management firm, will be responsible for accrual and retention of patients for HIV trials, and protocols for trials in patients with hepatitis C or both HIV and hepatitis C infections. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Their mean age was 57 ± 15 years. One patient had hepatitis‐C virus (HCV)‐related cryoglobulinemia and the other three patients were carriers of an IgM Kappa monoclonal gammopathy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This contrasts with hepatitis C or HIV where early treatment is recommended in all infected patients, regardless of end-organ damage. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Thymosin α1 (Tα1) is an immunostimulatory peptide that is commonly used as an immune enhancer in viral infectious diseases such as hepatitis B, hepatitis C, and acquired immune deficiency syndrome (AIDS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…These include the Epstein–Barr virus (EBV), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), Merkel cell polyomavirus (MCPyV), human herpesvirus 8 (HHV8), and human T-cell lymphotropic virus type 1 (HTLV-1). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In vivo assessment of PCPP-F demonstrated its greater ability to induce antibody responses to Hepatitis C virus antigen when compared to its non-fluorinated counterpart. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Similarly to other viral infections, human immunodeficiency virus type 1 (HIV-1) also modulates the host TLR response; therefore, a proper understanding of the response induced by human HIV-1 or co-infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), due to the common mode of transmission of these viruses, is essential for understanding HIV-1 pathogenesis during mono- or co-infection with HBV or HCV, as well as for HIV-1 cure strategies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Flaviviridae infections, such as those caused by hepatitis C (HCV) and dengue viruses (DENVs), represent global health risks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso